Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia
This study is currently recruiting participants.
Verified March 2013 by Mayo Clinic
Sponsor:
Mayo Clinic
Information provided by (Responsible Party):
Aref Al-Kali, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01670084
First received: August 17, 2012
Last updated: March 5, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2017 |
| Estimated Primary Completion Date: | September 2015 (Final data collection date for primary outcome measure) |